Cytosorb Device

Composition:
Introduction to Cytosorb Devices
Cytosorb device is a medical device used in critical care settings to remove inflammatory mediators from the bloodstream of patients with conditions such as sepsis, acute respiratory distress syndrome (ARDS), and cardiac surgery-associated inflammatory response syndrome (CARS). The body can produce excessive levels of cytokines in inflammation due to severe infection. This device removes these cytokine substances in your blood.

Cytosorb devices are used to treat patients aged 18 years and above with confirmed COVID-19 who are showing certain severe symptoms (including a persistent cough, high fever, developing more difficulty breathing). COVID-19 is a highly infectious disease caused by the SARS-CoV-2 virus. It is essential to inform your health care professional if you are pregnant or have any diseases or allergic conditions before starting treatment with Cytosorb devices.


Uses of Cytosorb Devices
Cytosorb devices use in the treatment of the following:

Treatment of COVID-19 patients with severe symptoms
Acute respiratory distress syndrome (ARDS)
Cardiac surgery-associated inflammatory response syndrome (CARS)

Therapeutic Effects of Cytosorb Devices
Cytosorb devices work by using a process called hemoadsorption to remove inflammatory mediators from the bloodstream of critically ill patients. Hemoadsorption is a method of blood purification in which blood is passed through a cartridge containing adsorbent material that selectively removes certain substances from the blood. It contains highly porous polymer beads with a large surface area that can selectively adsorb a range of inflammatory mediators, such as cytokines, chemokines, and endotoxins.